期刊文献+

非酒精性脂肪性肝病大鼠胰腺分泌状态及胰岛素抵抗观察 被引量:2

Secretory status of pancreas and pathogenesis of insulin resistance in rat with nonalcoholic fatty liver disease
下载PDF
导出
摘要 目的研究非酒精性脂肪性肝病(NAFLD)大鼠的胰岛分泌状态及胰岛素受体(IR)表达的动态变化。方法建立NAFLD大鼠模型,应用HE染色、免疫组化、ELISA等方法观察胰腺组织结构、分泌状态和IR的表达变化。结果模型大鼠胰腺组织结构及血糖水平无明显变化。血清胰岛素水平在造模后4周明显升高(P<0.01),而组织中胰岛素水平从6周开始增加(P<0.01),且主要分布于胰岛的中央部,并呈现出逐渐增加的趋势。组织中胰高血糖素水平从8周开始增加(P<0.01),于12周达高峰,而IR表达从6周开始明显减少(P<0.01),8周后趋于稳定。结论NAFLD大鼠胰岛素和胰高血糖素的总体表达水平呈上升趋势,但胰岛素在组织与血清中的表达并不完全一致,且IR表达量减少,这可能是NAFLD时发生胰岛素抵抗的重要原因之一。 Objective Rats with nonalcoholic fatty liver disease (NAFLD) were used to investigate the secretory state of pancreas and the expression of insulin receptor (IR). Methods NAFLD rat model was reproduced, and then the structure of pancreatic tissue, secretory states of α and β cells (serum, tissue) and the expression of IR were examined and determined by means of HE staining, ELISA, and immunohistochemistry. Results In all experimental groups, the structure of pancreatic tissue showed no obvious change; the blood sugar level tended to rise. The insulin level in serum began to elevate obviously at 4th week (P≤0.01), while the insulin content in tissue began to increase at 6th week (P≤0.01), and distributed mainly in the middle part of the pancreas with a tendency of elevation along with the time. The content of glucagon in pancreatic tissue began to increase at 8th week (P≤0.01), and reached the peak at 12th week. The expression of IR in tissue began to decrease at 6th week (P≤0.01), and then tended to be stable after 8th week. Conclusions In NAFLD, there was changes in secretory state of pancreas with the accompaniment of insulin resistance. There was a tendency of elevation of levels of insulin both in serum and pancreatic tissue, but the time of expression was different. The expression of glucagen shows an increase tendency, while the decrease of IR might be the crucial cause of insulin resistance in NAFLD.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2008年第4期379-381,共3页 Medical Journal of Chinese People's Liberation Army
基金 中国肝炎防治基金会研究基金资助课题(20070042)
关键词 非酒精性脂肪性肝病 胰腺 胰岛素 nonalcoholic fatty liver disease pancreas insulin
  • 相关文献

参考文献7

  • 1Nir T, Melton DA, Dor Y. Recovery from diabetes in mice by beta cell regeneration. J Clin Invest, 2007, 117(9):2553
  • 2Heit JJ, Apelqvist AA, Gu X, et al. Caicineurin/NFAT signalling regulates pancreatic beta-cell growth and function. Nature, 2006,443 (7109) :345
  • 3Bertacca A, Ciccarone A, Cecchetti P, et al. High insulin levels impair intracellular receptor trafficking in human cultured myoblasts. Diabetes Res Clin Pratt, 2007, 78(3):316
  • 4Singer G, Granger DN. Inflammatory responses underlying the microvascular dysfunction associated with obesity and insulin resistance. Microcirculation, 2007, 14(4-5):375
  • 5Angulo P, Alba LM, Petrovic LM, et al. Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease. J Hepatol, 2004,41(6) .-943
  • 6Mlinar B, Marc J, Janez A, et al. Molecular mechanisms of insulin resistance and associated diseases Clin Chim Acta, 2007, 375(1-2):20
  • 7Draznin B. Molecular mechanisms of insulin resistance: serine phosphorylation of insulin receptor substrate-1 and increased expression of p85 alpha: the two sides of a coin. Diabetes, 2006, 55(8):2392

同被引文献18

  • 1舒毅,钟历勇,石立.褪黑素、维生素E和还原型谷胱甘肽对四氧嘧啶糖尿病大鼠氧化应激影响的比较研究[J].东南大学学报(医学版),2006,25(2):88-92. 被引量:12
  • 2张冬梅,张桂英,王涛,钟惠菊,陈文科.改善胰岛素抵抗药物治疗大鼠非酒精性脂肪肝病的实验研究[J].中华医学杂志,2006,86(18):1279-1283. 被引量:14
  • 3Tominaga K,Fujimoto E,Suzuki K,et al.Prevalence of nonalco-holic fatty liver disease in children and relationship to metabolic syndrome,insulin resistance,and waist circumference.Environ Health Prev Med,2009,14:142-149.
  • 4Uchil D,Pipalia D,Chawla M,et al.Non-alcoholic fatty liver disease (NAFLD)--the hepatic component of metabolic syndrome.J Assoc Physicians India,2009,57:201-204.
  • 5Loria P,Lonardo A,Bellentani S,et al.Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease:an open question.Nutr Metab Cardiovasc Dis,2007,17:684-698.
  • 6Kohjima M,Higuchi N,Kato M,et al.SREBP-1c,regulated by the insulin and AMPK signaling pathways,plays a role in nonalcoholic fatty liver disease.Int J Mol Med,2008,21:507-511.
  • 7Longato L,de la Monte S,Kuzushita N,et al.Overexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liver.Hepatology,2009,49(6):1935-1943.
  • 8Wang CH,Leung CH,Liu SC,et al..Safety and Effectiveness of Rosiglitazone in Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease.J Formosan Med Asso,2006,105:743-752.
  • 9Von Montfort C,Matias L,Garcia-Ruiz C,et al.The mitocho-ndrial GSH level is responsible for the efficiency and the protective effect of superoxide elimination.J Hepatol,2009,50:265-266.
  • 10Tominaga K, Fujimoto E, Suzuki K, et at. Prevalence of non-alcoholic fatty liver disease in children and relationship to metabolic syndrome, insulin resistance, and waist circumference [ J ]. Environ Health Prey Med, 2009, 14(2): 142-149.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部